Yttrium-90 ibritumomab tiuxetan plus busulfan, cyclophosphamide, and etoposide (BuCyE) versus BuCyE alone as a conditioning regimen for non-Hodgkin lymphoma

BACKGROUND: Radioimmunotherapy agents have a highly significant role in autologous stem cell transplantation as they improve tolerability and increase the efficacy of the conditioning regimen. METHODS: We retrospectively analyzed the efficacy and toxicity of yttrium-90 ibritumomab tiuxetan (Zevalin)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Jae-Cheol, Yoon, Dok Hyun, Kim, Shin, Park, Jung Sun, Park, Chan-Sik, Huh, Jooryung, Lee, Sang-Wook, Ryu, Jin-Sook, Suh, Cheolwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389060/
https://www.ncbi.nlm.nih.gov/pubmed/22783358
http://dx.doi.org/10.5045/kjh.2012.47.2.119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389060/
https://www.ncbi.nlm.nih.gov/pubmed/22783358
http://dx.doi.org/10.5045/kjh.2012.47.2.119

Ejemplares similares